Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06128837 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Study of LY01610 in Patients With Recurrent Small Cell Lung Cancer

StatusRecruiting
PhasePhase 3
Started2024-03-03
View on ClinicalTrials.gov ↗

Amendment history

2024-03-12
Not Yet Recruiting→Recruiting Study Status, Contacts/Locations v1
Trial statusNot Yet Recruiting→Recruiting
Start dateestimated 2024-01→confirmed 2024-03-03
Study sitesdetails revised at 1 of 1 site
2023-11-07
Original filing
This is a multicenter，randomized, open label, active-controlled, parallel-group study comparing efficacy and safety of LY01610(Irinotecan hydrochloride liposome Injection) and Topotecan in Patients with Recurrent Small Cell Lung Cancer (SCLC)
Trial Details
NCT Number NCT06128837
Lead Sponsor Luye Pharma Group Ltd.
Conditions Relapsed Small Cell Lung Cancer
Enrollment 686 participants
Start Date 2024-03-03
Primary Completion 2028-06 (estimated)
Study Completion 2028-10 (estimated)
Updated on ClinicalTrials.gov 2024-03-15